Name: Talquetamab Biosimilar – Anti-GPRC5D/CD3 Bispecific Antibody
Brand: BroadPharm
SKU: BP-50622
Price: 450.00 USD
Availability: InStock

Talquetamab Biosimilar – Anti-GPRC5D/CD3 Bispecific Antibody

Catalog #: bp-50622

Catalog #

Unit

Price

BP-50622

1 MG

$450.00

BP-50622

5 MG

$1200.00

BP-50622

10 MG

$2300.00

BP-50622

25 MG

$3800.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?

Inquire

Overview

Talquetamab (sold under the brand name Talvey) is a first-in-class bispecific antibody used to treat heavily pretreated, relapsed or refractory multiple myeloma. Administered via subcutaneous injection, it directs the body's T cells to hunt down cancer cells by targeting both CD3 receptors and GPRC5D. Talquetamab is indicated for adults with multiple myeloma who have received at least four prior treatment regimens, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

Product Details
Species Reactivity	Human
Source	Mammalian cells
Host/Isotype	Ig(G4-kappa_G4-lambda2)
Class	Bispecific Antibody
Type	Recombinant Humanized
Conjugate	Unconjugated
Molecular Weight	144.58 kDa
Storage Condition	Store at -80°C for 2 years. Aliquots should be stored at the same temperature after first use to avoid multiple freeze-thaws.

Application

ELISA, FACS, Functional assay
Images
Datasheets and Documents

Datasheet BP-50622.pdf

Talquetamab Biosimilar – Anti-GPRC5D/CD3 Bispecific Antibody